BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizoguchi K, Ikarashi Y. Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects. Front Pharmacol 2017;8:149. [PMID: 28377723 DOI: 10.3389/fphar.2017.00149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Ishibashi Y, Nishitani R, Shimura A, Takeuchi A, Touko M, Kato T, Chiba S, Ashidate K, Ishiwata N, Ichijo T, Sasabe M. Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study. PLoS One 2020;15:e0238723. [PMID: 32916693 DOI: 10.1371/journal.pone.0238723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
2 Takayama S, Tomita N, Arita R, Ono R, Kikuchi A, Ishii T. Kampo Medicine for Various Aging-Related Symptoms: A Review of Geriatric Syndrome. Front Nutr 2020;7:86. [PMID: 32766269 DOI: 10.3389/fnut.2020.00086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
3 Matsumoto T, Ikarashi Y, Takiyama M, Watanabe J, Setou M. Brain distribution of geissoschizine methyl ether in rats using mass spectrometry imaging analysis. Sci Rep 2020;10:7293. [PMID: 32350314 DOI: 10.1038/s41598-020-63474-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
4 Han C, Kawata M, Hamada Y, Kondo T, Wada J, Asano K, Makabe H, Igarashi K, Kuzumaki N, Narita M, Kobayashi H, Narita M. Analyses of the possible anti-tumor effect of yokukansan. J Nat Med 2019;73:468-79. [PMID: 30739283 DOI: 10.1007/s11418-019-01283-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Matsumoto T, Sekiguchi K, Kawakami Z, Watanabe J, Mizoguchi K, Ikarashi Y, Yamamoto M. Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan. Molecules 2018;24:E115. [PMID: 30597998 DOI: 10.3390/molecules24010115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Jang JH, Jung K, Kim JS, Jung I, Yoo H, Moon C. Potential Application of Yokukansan as a Remedy for Parkinson's Disease. Evid Based Complement Alternat Med 2018;2018:1875928. [PMID: 30671124 DOI: 10.1155/2018/1875928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kaushik R, Morkovin E, Schneeberg J, Confettura AD, Kreutz MR, Senkov O, Dityatev A. Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease. Front Aging Neurosci 2018;10:411. [PMID: 30631278 DOI: 10.3389/fnagi.2018.00411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
8 Jang JH, Lee J, Jung I, Yoo H. Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial. Medicine (Baltimore) 2018;97:e11298. [PMID: 29953013 DOI: 10.1097/MD.0000000000011298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Mizoguchi K, Ikarashi Y. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol 2017;8:655. [PMID: 28979206 DOI: 10.3389/fphar.2017.00655] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
10 Hein M, Mungo A, Hubain P, Loas G. Excessive daytime sleepiness in adolescents: current treatment strategies. Sleep Sci 2020;13:157-71. [PMID: 32742588 DOI: 10.5935/1984-0063.20190143] [Cited by in F6Publishing: 3] [Reference Citation Analysis]